PAA 0.00% 20.0¢ pharmaust limited

Ann: Appendix 4C and Quarterly Update, page-28

  1. 313 Posts.
    lightbulb Created with Sketch. 99
    Hey NZ - They can't put in a time-frame for emergency approval granted for use of MPL in Europe / US into a timeline , they have to base it off normal processes otherwise it would be misleading to shareholders and illegal.

    At any point next year we could move fast towards use in humans fast tracked if MPL works well - that's a given. They just can't rely on that or promote it in a SH update. There is always this chance.

    These timelines are exactly what I was expecting when investing in PAA and are happy to have them out in the open. I'm not concerned at all and actually really excited for the year ahead and any new investor would be as well.



 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.000(0.00%)
Mkt cap ! $97.24M
Open High Low Value Volume
20.0¢ 20.0¢ 19.5¢ $244.3K 1.244M

Buyers (Bids)

No. Vol. Price($)
1 100000 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 257206 7
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.